NCT04777474

Brief Summary

The focus of the study is to verify the role of enhanced contact endoscopy in early identification of high-risk vascular patterns of precancerous and malignant mucosal changes in ear-nose-throat (ENT) patients, in comparison with other standard imaging techniques.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2021

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2021

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 2, 2021

Completed
2 months until next milestone

Study Start

First participant enrolled

May 15, 2021

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2023

Completed
Last Updated

December 7, 2022

Status Verified

December 1, 2022

Enrollment Period

2.5 years

First QC Date

February 23, 2021

Last Update Submit

December 6, 2022

Conditions

Keywords

laryngeal cancerhypopharyngeal cancerlaryngeal diseaseenhanced contact endoscopynarrow band imagingIMAGE1S method

Outcome Measures

Primary Outcomes (5)

  • Accuracy of enhanced contact endoscopy

    The accuracy of enhanced contact endoscopy will be observed (size of lesions in mm when compared with the other standard techniques)

    Procedure (During the examination under general anaesthesia)

  • Sensitivity of enhanced contact endoscopy

    The sensitivity of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.

    Procedure (During the examination under general anaesthesia)

  • Specificity of enhanced contact endoscopy

    The specificity of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.

    Procedure (During the examination under general anaesthesia)

  • Positive predictive value of enhanced contact endoscopy

    The positive predictive value of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.

    Procedure (During the examination under general anaesthesia)

  • Negative predictive value of enhanced contact endoscopy

    The negative predictive value of enhanced contact endoscopy in making pre-histological diagnosis using final histopathology result. will be observed.

    Procedure (During the examination under general anaesthesia)

Study Arms (1)

Enhanced contact endoscopy

EXPERIMENTAL

The study subjects will undergo enhanced contact endoscopy

Diagnostic Test: Enhanced contact endoscopyDiagnostic Test: Narrow band imagingDiagnostic Test: IMAGE1S imaging

Interventions

The study subjects will undergo enhanced contact endoscopy - studied imaging technique

Enhanced contact endoscopy
Narrow band imagingDIAGNOSTIC_TEST

The study subjects will undergo narrow band imaging - comparator procedure

Enhanced contact endoscopy
IMAGE1S imagingDIAGNOSTIC_TEST

The study subjects will undergo IMAGE1S imaging - comparator procedure

Enhanced contact endoscopy

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and older
  • patients scheduled for direct hypopharyngoscopy and laryngoscopy in general anaesthesia
  • benign laryngeal and hypoharyngeal disease/laryngeal and hypopharyngeal lesions of uncertain biologic behaviour (leukoplakia, erythroplakia, keratosis)
  • patients with suspicious macroscopical lesion found during ENT examination/patients with histologically confirmed metastasis of carcinoma in neck lymph node with unknown primary origin of the tumour
  • patients with recurrence of malign tumour in hypopharynx or larynx
  • patients after radiotherapy indicated for follow up examination under general anaesthesia
  • patients with persistent non-specific problems (hoarseness, swallowing problems etc.) indicated to direct laryngohypopharyngoscopy due to diagnostic purposes

You may not qualify if:

  • age - younger than 17 years
  • refusal to join the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University Hospital Ostrava

Ostrava, Moravian-Silesian Region, 70852, Czechia

RECRUITING

University Hospital Hradec Králové

Hradec Králové, Czechia

RECRUITING

Related Publications (2)

  • Puxeddu R, Sionis S, Gerosa C, Carta F. Enhanced contact endoscopy for the detection of neoangiogenesis in tumors of the larynx and hypopharynx. Laryngoscope. 2015 Jul;125(7):1600-6. doi: 10.1002/lary.25124. Epub 2015 Jan 13.

    PMID: 25582112BACKGROUND
  • Mehlum CS, Dossing H, Davaris N, Giers A, Grontved AM, Kjaergaard T, Moller S, Godballe C, Arens C. Interrater variation of vascular classifications used in enhanced laryngeal contact endoscopy. Eur Arch Otorhinolaryngol. 2020 Sep;277(9):2485-2492. doi: 10.1007/s00405-020-06000-z. Epub 2020 Apr 30.

    PMID: 32350646BACKGROUND

MeSH Terms

Conditions

Laryngeal DiseasesLaryngeal NeoplasmsHypopharyngeal Neoplasms

Interventions

Narrow Band Imaging

Condition Hierarchy (Ancestors)

Respiratory Tract DiseasesOtorhinolaryngologic DiseasesOtorhinolaryngologic NeoplasmsHead and Neck NeoplasmsNeoplasms by SiteNeoplasmsRespiratory Tract NeoplasmsPharyngeal NeoplasmsPharyngeal DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Optical ImagingDiagnostic ImagingDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques

Study Officials

  • Peter Kántor, MD

    University Hospital Ostrava

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jiří Hynčica

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
No masking is being used in the study
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: The study subjects will be enrolled into one study group.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2021

First Posted

March 2, 2021

Study Start

May 15, 2021

Primary Completion

December 1, 2023

Study Completion

December 1, 2023

Last Updated

December 7, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

There is no plan to make individual participant data available to other researchers. The data may be provided upon request.

Locations